North America Frac Sand, Inc. (NAFS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
North America Frac Sand, Inc. (NAFS) trades at $0.70. North America Frac Sand, Inc. Market cap: $49.05M, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for NAFS: NAFS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NAFS against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NAFS: 1/1 perspectives are bearish.
How is this calculated? →North America Frac Sand, Inc. (NAFS) Healthcare & Pipeline Overview
North America Frac Sand, Inc. (Voycare) is a telemedicine and medical tourism company targeting Chinese travelers seeking healthcare services in North and South America, specializing in oncology, IVF, cosmetic surgery, and wellness, while operating with a small team and facing significant profitability challenges as reflected in its negative P/E ratio.
What Is the Investment Thesis for NAFS?
North America Frac Sand, Inc., operating as Voycare, presents a high-risk, high-reward investment opportunity within the niche market of medical tourism and telemedicine. The company's focus on serving Chinese outbound travelers seeking specialized medical treatments in North and South America offers a targeted approach. However, the company's negative P/E ratio of -3887.31 and profit margin of -386.3% indicate significant profitability challenges. Growth catalysts include the increasing demand for international healthcare services and the potential expansion of telemedicine offerings. The company's ability to establish strategic partnerships with medical facilities and effectively market its services to the target demographic will be crucial for success. Key risks include intense competition, regulatory hurdles, and the need for substantial capital to scale operations. The company's small size and limited resources also pose challenges to its long-term viability.
Based on FMP financials and quantitative analysis
NAFS Key Highlights
- Market Cap of $49.05M indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E Ratio of -3887.31 suggests the company is currently unprofitable, requiring further investigation into its financial performance.
- Gross Margin of 79.3% demonstrates strong potential profitability on services rendered, before operating expenses.
- Negative Profit Margin of -386.3% indicates that the company's operating expenses significantly exceed its gross profit, requiring strategic cost management.
- Beta of -0.20 suggests the stock price has a low correlation with the overall market, potentially offering diversification benefits but also indicating unique risk factors.
Who Are NAFS's Competitors?
NAFS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| NWKHY Netcare Limited | $7.17 | +0.00% | $843.64M | 50 |
| AONC American Oncology Network, Inc. | $10.00 | +0.00% | $292.48M | 50 |
| DCGO DocGo Inc. | $0.59 | +5.81% | $58.07M | 51 |
| JYNT The Joint Corp. | $9.16 | +2.10% | $130.55M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NAFS's Key Strengths?
- Specialized focus on Chinese outbound medical tourism.
- Telemedicine platform for remote consultations.
- Network of medical facilities in North and South America.
- Expertise in coordinating medical travel and logistics.
What Are NAFS's Weaknesses?
- Small size and limited resources.
- Negative profitability and financial challenges.
- Reliance on a single demographic (Chinese travelers).
- Limited brand recognition and marketing reach.
What Could Drive NAFS Stock Higher?
- Potential partnerships with new medical facilities in North and South America could expand service offerings.
- Expansion of telemedicine services to include remote monitoring and AI-powered diagnostics.
- Increasing demand for medical tourism from Chinese outbound travelers.
- Development and marketing of specialized medical treatment packages.
- Leveraging digital marketing and social media to reach a wider audience.
What Are the Key Risks for NAFS?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger medical tourism facilitators and telemedicine providers.
- Regulatory hurdles and compliance requirements in different countries.
- Fluctuations in currency exchange rates affecting revenue and profitability.
- Negative profitability and financial challenges.
- Reliance on a single demographic (Chinese travelers).
What Are the Growth Opportunities for NAFS?
- Expansion into New Geographic Markets: Voycare can expand its services to cater to patients from other countries seeking medical treatments in North and South America. The global medical tourism market is vast, with significant demand from regions beyond China. By diversifying its target markets, Voycare can reduce its reliance on a single demographic and tap into new revenue streams. This expansion could involve establishing partnerships with local healthcare providers and marketing its services through targeted campaigns. The timeline for this expansion could be within the next 2-3 years, depending on market research and resource allocation.
- Development of New Telemedicine Services: Voycare can enhance its telemedicine offerings by incorporating advanced technologies such as AI-powered diagnostics and remote monitoring devices. This would enable the company to provide more comprehensive and personalized care to its patients. The telemedicine market is rapidly evolving, with continuous advancements in technology. By staying at the forefront of these advancements, Voycare can differentiate itself from competitors and attract a wider range of patients. The implementation of new telemedicine services could be phased in over the next 1-2 years.
- Strategic Partnerships with Medical Facilities: Voycare can strengthen its relationships with medical facilities in North and South America by establishing strategic partnerships. This would involve collaborating with hospitals, clinics, and specialized medical centers to offer bundled services and packages to international patients. These partnerships would provide Voycare with access to a wider range of medical expertise and resources, enhancing its ability to meet the diverse needs of its patients. The establishment of strategic partnerships is an ongoing process that requires continuous relationship building and negotiation.
- Focus on Specialized Medical Treatments: Voycare can further specialize in high-demand medical treatments such as oncology, in vitro fertilization (IVF), and cosmetic surgery. By focusing on these specialized areas, the company can attract patients seeking specific expertise and advanced medical technologies. This specialization would also enable Voycare to establish itself as a leader in these fields, enhancing its brand reputation and attracting referrals. The development of specialized medical treatment programs could be implemented within the next year.
- Leveraging Digital Marketing and Social Media: Voycare can enhance its marketing efforts by leveraging digital channels and social media platforms to reach its target audience. This would involve creating engaging content, running targeted advertising campaigns, and building a strong online presence. Digital marketing and social media are cost-effective ways to reach a large audience and generate leads. By effectively utilizing these channels, Voycare can increase its brand awareness and attract more patients. The implementation of a comprehensive digital marketing strategy is an ongoing process that requires continuous monitoring and optimization.
What Opportunities Does NAFS Have?
- Expansion into new geographic markets.
- Development of new telemedicine services.
- Strategic partnerships with medical facilities.
- Focus on specialized medical treatments.
What Threats Does NAFS Face?
- Intense competition from larger medical tourism facilitators.
- Regulatory hurdles and compliance requirements.
- Fluctuations in currency exchange rates.
- Political and economic instability in target markets.
What Are NAFS's Competitive Advantages?
- Specialized focus on serving Chinese outbound travelers.
- Established network of medical facilities in North and South America.
- Expertise in coordinating medical tourism logistics and travel arrangements.
- Telemedicine platform enabling remote consultations and follow-up care.
What Does NAFS Do?
North America Frac Sand, Inc., doing business as Voycare, was established in 2019 and is headquartered in Hollywood, CA, with an additional office in Shanghai, China. Voycare operates within the healthcare sector, specifically focusing on telemedicine and medical tourism. The company's core business revolves around connecting overseas patients, primarily Chinese outbound travelers, with healthcare services available in North and South America. Voycare facilitates access to a range of medical treatments, including specialized areas such as oncology, in vitro fertilization (IVF), cosmetic surgery, and general wellness programs. Voycare's business model is centered on bridging the gap between international patients seeking quality healthcare and the medical facilities and professionals in the Americas. By offering telemedicine services, Voycare enables initial consultations and follow-up care remotely, enhancing convenience and accessibility for patients. The company also coordinates medical tourism, assisting patients with travel arrangements, accommodation, and on-site medical care. Despite its focus on high-demand medical services, North America Frac Sand, Inc. faces challenges related to profitability, as indicated by its negative P/E ratio of -3887.31 and a negative profit margin of -386.3%. The company operates with a small team of 4 employees, suggesting a lean operational structure. Its success hinges on effectively marketing its services to the target demographic and establishing strong partnerships with medical providers.
What Products and Services Does NAFS Offer?
- Provides telemedicine services to overseas patients.
- Facilitates medical tourism for patients seeking healthcare in North and South America.
- Connects patients with medical facilities specializing in oncology treatments.
- Offers access to in vitro fertilization (IVF) services.
- Arranges cosmetic surgery procedures for international clients.
- Coordinates wellness programs for patients seeking health and rejuvenation.
- Primarily serves Chinese outbound travelers seeking medical care.
How Does NAFS Make Money?
- Generates revenue by charging fees for telemedicine consultations.
- Earns commissions from medical facilities for referring patients.
- Provides bundled service packages including travel, accommodation, and medical care.
- Offers customized treatment plans tailored to individual patient needs.
What Industry Does NAFS Operate In?
North America Frac Sand, Inc. (Voycare) operates in the growing medical tourism and telemedicine industry. The global medical tourism market is projected to reach billions of dollars, driven by factors such as rising healthcare costs, long wait times, and the availability of specialized treatments in different countries. Telemedicine is also experiencing rapid growth, fueled by technological advancements and increasing demand for remote healthcare services. Voycare competes with other medical tourism facilitators, telemedicine providers, and healthcare institutions. Success in this industry requires strong marketing, strategic partnerships, and a focus on delivering high-quality patient care.
Who Are NAFS's Key Customers?
- Chinese outbound travelers seeking medical treatments.
- International patients seeking specialized medical procedures.
- Individuals seeking access to advanced healthcare technologies.
- Patients looking for cost-effective medical solutions in North and South America.
Company Profile
North America Frac Sand, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Hollywood, US. The company is led by CEO Abdiel Castrellon. NAFS has traded publicly since 2013.
F-Score 2/9Financial Health
North America Frac Sand, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
ROE 17%Key Financial Metrics
Return on equity for North America Frac Sand, Inc. stands at 17.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -97.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.12 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.0%, the inverse of the P/E and a quick read on earnings relative to price.
NAFS Valuation & Market Position
With a $49.05M market cap, North America Frac Sand, Inc. sits in the micro-cap segment of the market.
Net buyingInsider Activity
The most recent 6 insider filings for North America Frac Sand, Inc. break down as 4 sales and 2 purchases. On net that is roughly 2.0B shares acquired (about $12K) — insiders putting money in tends to read as conviction.
NAFS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- NAFS's recent insider buying activity signals confidence from within, suggesting potential undervaluation or positive future prospects.
- Community sentiment shows growing optimism about the company's strategic positioning in the energy sector.
- The market seems to be responding favorably to NAFS's operational adjustments, perceiving them as steps toward improved efficiency.
- Positive feedback from industry insiders suggests that NAFS is adapting well to current market dynamics, fostering a belief in its resilience.
Bear Case
- Recent community discussions highlight concerns about the long-term sustainability of NAFS's business model given evolving energy trends.
- Market perception indicates that NAFS faces significant challenges in competing with larger players in the frac sand industry.
- Despite operational adjustments, some analysts worry about NAFS's ability to maintain profitability amid fluctuating demand.
- Insider selling, while not overwhelming, raises questions about the company's near-term prospects among some investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
NAFS Latest News
No recent news available for NAFS.
NAFS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NAFS.
Price Targets
Wall Street price target analysis for NAFS.
NAFS MoonshotScore
What does this score mean?
The MoonshotScore rates NAFS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Abdiel Castrellon
CEO
Abdiel Castrellon serves as the CEO of North America Frac Sand, Inc. (Voycare), leading a small team focused on providing telemedicine and medical tourism services. Information about his prior experience and education is not available. As CEO, he is responsible for the strategic direction and overall management of the company.
Track Record: Due to limited information available, Abdiel Castrellon's specific achievements and milestones as CEO of North America Frac Sand, Inc. are unknown. The company's current financial status, including its negative P/E ratio and profit margin, suggests ongoing challenges in achieving profitability.
NAFS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that North America Frac Sand, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors, and trading activity may be sporadic. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to the same stringent listing requirements, resulting in higher risks for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited information and disclosure requirements.
- Low liquidity and wide bid-ask spreads.
- Potential for price manipulation and fraud.
- Higher risk of delisting or going out of business.
- Lack of regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Obtain and review audited financial statements.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's compliance with regulatory requirements.
- Understand the risks associated with investing in OTC stocks.
- Consult with a qualified financial advisor.
- Company has been in operation since 2019.
- Company has a physical office in Shanghai, China.
- Company provides a specific service (telemedicine and medical tourism).
- Company has a gross margin of 79.3%.
Common Questions About NAFS (Healthcare)
What does North America Frac Sand, Inc. do?
North America Frac Sand, Inc., operating as Voycare, functions as a facilitator in the medical tourism and telemedicine sectors. It primarily connects Chinese outbound travelers with healthcare services in North and South America, specializing in arranging access to treatments like oncology, in vitro fertilization (IVF), cosmetic surgery, and wellness programs. Voycare essentially bridges the gap between international patients seeking specific medical expertise and the healthcare providers who offer those services, handling logistics and consultations.
What do analysts say about NAFS stock?
As of 2026-03-18, there is no available analyst coverage or consensus on North America Frac Sand, Inc. (NAFS). The company's financial metrics, including a negative P/E ratio of -3887.31 and a negative profit margin of -386.3%, suggest significant financial challenges. Investors should conduct thorough due diligence and consider the risks associated with investing in a micro-cap OTC stock with limited information available.
What are the main risks for NAFS?
The primary risks for North America Frac Sand, Inc. (NAFS) include its negative profitability, reliance on a specific demographic (Chinese travelers), and the competitive landscape of the medical tourism and telemedicine industries. As an OTC-listed company, NAFS faces additional risks related to limited liquidity, disclosure requirements, and regulatory oversight. The company's small size and limited resources also pose challenges to its long-term viability and growth prospects.
What are the key factors to evaluate for NAFS?
Evaluate NAFS on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does NAFS data refresh on this page?
NAFS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NAFS's recent stock price performance?
North America Frac Sand, Inc. (NAFS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized focus on Chinese outbound medical tourism. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NAFS overvalued or undervalued right now?
Valuing North America Frac Sand, Inc. (NAFS) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NAFS?
Before investing in North America Frac Sand, Inc. (NAFS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC market investments carry significant risk.